Valuation Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 21:00:27 12/05/2026 BST			Pre-market 14:09:56
112.37 ^USD	+0.98%		112.87	+0.44%

05-12	Merck highlights new long-term data and advancements across broad oncology portfolio and pipeline research at Asco 2026	RE
05-12	Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research At Asco 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	193,588	281,302	276,259	251,648	261,258	277,534	-	-
Change	-	45.31%	-1.79%	-8.91%	3.82%	6.23%	-	-
Enterprise Value (EV) ¹	218,594	298,801	304,221	275,517	296,032	312,182	299,125	282,366
Change	-	36.69%	1.81%	-9.44%	7.45%	5.46%	-4.18%	-5.6%
P/E ratio	14.9x	19.4x	779x	14.8x	14.5x	50.1x	13.5x	11.7x
PBR	5.07x	6.12x	7.34x	5.44x	5.01x	5.7x	4.73x	3.89x
PEG	-	1.7x	-8x	0x	1.81x	-0.7x	0x	0.8x
Capitalization / Revenue	3.97x	4.75x	4.6x	3.92x	4.02x	4.15x	3.94x	3.68x
EV / Revenue	4.49x	5.04x	5.06x	4.29x	4.55x	4.67x	4.25x	3.74x
EV / EBITDA	10.5x	11.3x	30.2x	9.88x	9.08x	17.5x	8.8x	7.7x
EV / EBIT	12.4x	13.3x	49x	11.8x	11.1x	23.8x	10.3x	8.86x
EV / FCF	25.2x	20.3x	33.3x	15.2x	24x	26.6x	13.1x	11.3x
FCF Yield	3.97%	4.92%	3.01%	6.57%	4.18%	3.75%	7.63%	8.88%
Dividend per Share ²	2.64	2.8	2.96	3.12	3.28	3.33	3.463	3.674
Rate of return	3.44%	2.52%	2.72%	3.14%	3.12%	2.96%	3.08%	3.27%
EPS ²	5.14	5.71	0.14	6.74	7.28	2.241	8.312	9.604
Distribution rate	51.4%	49%	2,114%	46.3%	45.1%	149%	41.7%	38.3%
Net sales ¹	48,704	59,283	60,115	64,168	65,011	66,849	70,367	75,453
EBITDA ¹	20,910	26,431	10,083	27,897	32,617	17,864	34,004	36,649
EBIT ¹	17,696	22,522	6,211	23,398	26,779	13,097	29,022	31,885
Net income ¹	13,049	14,519	365	17,117	18,254	5,556	20,425	23,378
Net Debt ¹	25,006	17,499	27,962	23,869	34,774	34,648	21,591	4,832
Reference price ²	76.64	110.95	109.02	99.48	105.26	112.37	112.37	112.37
Nbr of stocks (in thousands)	2,525,944	2,535,396	2,534,023	2,529,636	2,482,023	2,469,824	-	-
Announcement Date	03/02/22	02/02/23	01/02/24	04/02/25	03/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
MERCK & CO., INC.	50.13x	4.67x	17.48x	2.96%	278B
ELI LILLY AND COMPANY	29.04x	10.54x	21.76x	0.69%	883B
JOHNSON & JOHNSON	23.97x	5.53x	15.03x	2.38%	540B
ABBVIE INC.	25.34x	6.27x	12.75x	3.3%	367B
ROCHE HOLDING AG	17x	4.26x	10.49x	3.12%	328B
ASTRAZENECA PLC	23.38x	4.85x	13.78x	1.8%	288B
NOVARTIS AG	20.45x	5.51x	13.4x	3.04%	283B
NOVO NORDISK A/S	13.42x	4.92x	10.04x	3.76%	206B
AMGEN INC.	21.62x	5.9x	10.23x	3%	181B
GILEAD SCIENCES, INC.	-48.77x	5.82x	32.51x	2.41%	168B
Average	17.56x	5.83x	15.75x	2.64%	352.13B
Weighted average by Cap.	22.27x	6.62x	16.31x	2.29%